Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: HardToFind who wrote (10579)	6/21/2018 5:57:29 PM
From: HardToFind	Read Replies (1) \| Respond to of 12871

I should add that I think Dr. Diwan has interests as follows (in the following order): Personal, financial self-interest Interest in seeing the technology succeed Interest in making NNVC, the business, succeed. Interest in rewarding the shareholders for their contribution to the effort. I think this is displayed as follows: He's willing to screw the shareholders for the NNVC company entity's success. (If we all get massively diluted, it will be an example of this.) He's willing to screw the NNVC business in the interest of developing the technology. (This is evidenced by having TheraCour take back the licenses with no compensation to NNVC in the case of bankruptcy.) He's willing to screw the technology for his own financial self-interest. (This is evidenced by his unwillingness to date to change the licensing deal to adequately compensate investors, which I believe will lead to difficulty raising further equity capital for further drug development under attractive terms.) Only after the NNVC working capital dries up will he make other deals from TheraCour...similarly oppressive deals, if he can swing them. Time will tell...